Generic Drugs

World Market Report

MCP12162

EXECUTIVE ENGAGEMENTS

POOL

1974
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

353
Interactions with Platform & by Email

PARTICIPANTS

79
Unique # Participated

VALIDATIONS

18
Responses Validated*

COMPANIES

42
Responses Validated*
* Login for a full stack data experience

DATE

FEB 2022

TABLES

125

PAGES

641

EDITION

7

PRICE

USD 5450

CODE

MCP12162


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

STRONG ACTIVE NICHE TRIVIAL

%

VALIDATED RESEARCH *

S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year


Global Generic Drugs Market to Reach $507.8 Billion by 2026

Generic drugs are described as the bioequivalent versions of branded drugs in terms of safety, quality, stability, impact, strength, dosage form, and route of administration. Over the years, generic drugs have emerged as safe and effective alternatives to the brand name formulations. The generic variants differ from brand names in terms of certain characteristics such as color, flavoring and shape, although these factors do not have any impact on the safety and efficacy of the medicines compared to the original version. Generic drugs are drugs that are manufactured with the same active ingredient present in branded drugs and also yield the same therapeutic impact as their branded counterparts. The drugs are also prescribed in same amount as the branded drugs. Consumption method (administration route) is also similar to the branded drugs. Generic drugs are allowed to be marketed only after expiration of patents of branded drugs. The drugs are offered at much lower prices even though they are manufactured using the same stringent manufacturing and safety procedures and maintain equivalent quality. A key advantage for generic drug makers is that they do not need to invest time and money into drug R&D and marketing efforts, whereby the generic drugs are priced considerably low compared to branded counterparts.

Amid the COVID-19 crisis, the global market for Generic Drugs estimated at US$402.9 Billion in the year 2022, is projected to reach a revised size of US$507.8 Billion by 2026, growing at a CAGR of 5.6% over the analysis period. Small-Molecule Generics, one of the segments analyzed in the report, is projected to grow at a 5.2% CAGR to reach US$325.7 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biosimilars segment is readjusted to a revised 6.3% CAGR for the next 7-year period. This segment currently accounts for a 37.7% share of the global Generic Drugs market. With several growth encouraging factors contributing to wider uptake, biosimilars are poised to augment their share in the world generic drugs market in the coming years. The rise of biosimilars has in particular curtailed the overall spending on pharmaceutical drugs in recent years, a trend expected to continue in the foreseeable future. The emergence of biosimilars on the market is leading to heightened competition, the next generation of biologicals under development are aimed at improving safety, efficacy and cost factors over previous generation drugs further add to the competitive heat in the market.

The U.S. Market is Estimated at $121.8 Billion in 2022, While China is Forecast to Reach $91.2 Billion by 2026

The Generic Drugs market in the U.S. is estimated at US$121.8 Billion in the year 2022. The country currently accounts for a 30.46% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$91.2 Billion in the year 2026 trailing a CAGR of 7.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR while Rest of European market (as defined in the study) will reach US$97.6 Billion by the close of the analysis period.

The market is expected to be driven by the steadily rising risk of various chronic diseases such as hypertension, obesity and diabetes. Though pharma companies continue to develop branded drugs due to the dearth of new blockbuster drugs coming into the marketplace, generic drugs are expected to continue meeting the majority of these therapeutic needs of the population, especially the expanding elderly population. With high cost of branded medication becoming a financial burden for people, efforts have intensified to develop cost effective generic variants. Several branded drugs are unable to extend their exclusivity leading to loss of patents and giving way to the manufacture of affordable generics. Major application areas for generic drugs include cardiology, anti-infection, anti-arthritis, CNS, anti-cancer and respiratory among others. Generic drugs for CVDs represent the dominant segment currently, accounting for majority share in the overall market. Cardiovascular diseases such as heart failure, high BP, circulatory disorders, dyslipidemia, cholesterol, arrhythmias, stroke and angina are the major causes of global deaths. The cardiovascular segment is expected to cover a larger part of the global generic drug market owing to several patent expirations of these drugs. Generic drugs for infectious diseases would gain much traction over the coming years mainly because of increasing number of cases worldwide. The COVID-19 pandemic emerged as a significant growth driver for generic drugs market over the past one year. As economies of nations crashed because of increasing unemployment, the demand for cheaper substitutes of branded drugs increased.

SELECT PLAYERS

Abbott Laboratories; Apotex Inc.; ASKA Pharmaceutical Co., Ltd.; Aspen Pharmacare Holdings Limited; AstraZeneca Plc; Baxter International Inc.; Dr. Reddy’s Laboratories Limited; Eli Lilly and Company; Endo International plc; Fresenius Kabi; GlaxoSmithKline Plc.; H. Lundbeck A/S; Hospira; Lupin Pharmaceuticals, Inc.; Mylan N.V.; Novartis International AG; Novo Nordisk A/S; F. Hoffmann-La Roche AG; Sandoz International GmbH; Sanofi-Aventis U.S. LLC; STADA Arzneimittel AG; Sun Pharma; Teva Pharmaceutical Industries Ltd.

SEGMENTS

» Type (Small-Molecule Generics, Biosimilars) » Therapeutic Application (Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory, Other Therapeutic Applications)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Generic Drugs – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
The Race Between the Virus & Vaccines Intensifies. Amidst this Chaotic Battle, Where is the World Economy Headed in 2021?
EXHIBIT 1: How Fast the World is Vaccinated Will Determine How Soon the Pandemic Will End: Global Number of Annual COVID-19 Vaccine Doses (In Million) for Years 2020 through 2025 by Geographic Region/Country
Progress on Vaccinations, Why Should Businesses Care?
These are Times When Questions Abound & Answers Are Few
With IMF’s Upward Revision of Global GDP Forecasts for 2021, Most Companies Are Bullish About a Global Economic Comeback.
EXHIBIT 2: A Strong 2021 Economic Rebound Based On Pent-Up Demand Comes as a Relief for Suffering Industries & Markets: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
How the Healthcare Industry Has & Continues to be Impacted by the Pandemic & What’s the New Normal?
EXHIBIT 4: With the COVID-19 Pandemic Exposing Global Healthcare Unpreparedness, There is Increasing Policy Led Focus on Rebooting Health Systems Worldwide: Current & Required Healthcare Spending as % of GDP
Impact of COVID-19 Crisis on Generic Drugs Market
Demand for Generic Pain Killers Rises
A Prelude to Generic Drugs
Generic Drugs Market Set for a Rapid Growth
US Dominates, Asia-Pacific to Exhibit the Fastest Growth
India- A Significant Market
Market Restraints
Competition
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Patent Expiries Set to Widen the Addressable Market for Generic Drugs
Patent Expiries of Select Drugs in 2020
Patent Expiries of Select Drugs in 2021
Patent Expiries of Select Drugs in 2022
EXHIBIT: Patent Expiry of Select Major Drugs in the US: 2020-2022
Robust Demand for Pharmaceutical Drugs Drives Demand for Generic Drugs
Cost Containment Measures Put Focus on Generics
Small Molecule Generics Represent the Dominant Segment
Increasing Demand for Biosimilars, Driven by Patent Expiry of Major Biopharmaceutical Drugs
Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
Progressive Regulatory Framework Accelerates Product Approvals & Subsequently Market Revenues
Specific Guidelines for Biosimilars in Various Countries with Year of Publication
Biosimilars Regulatory Agencies in Select Regional Markets
Biosimilar Approvals in the US (as of February 2021)
Biosimilar Approvals in Europe (as of January 2021)
Rising Healthcare Costs Drive Demand for Generic Drugs
EXHIBIT 15: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Aging Population to Propel the Demand for Generic Drugs
EXHIBIT 13: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Rising Prevalence of Chronic Diseases Drive the Demand for Generic Drugs
Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
EXHIBIT: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
EXHIBIT 9: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT 11: Number of New Cancer Cases and Deaths (in Million) by Region for 2018
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Generic Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Generic Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Generic Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Small-Molecule Generics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Small-Molecule Generics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Small-Molecule Generics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Biosimilars by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Biosimilars by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biosimilars by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Central Nervous System (CNS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Central Nervous System (CNS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Central Nervous System (CNS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Dermatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Respiratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Respiratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Respiratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Therapeutic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Therapeutic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Therapeutic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
A Prelude to Generic Drugs
UNITED STATES
Generic Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
JAPAN
Generic Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
CHINA
Generic Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
EUROPE
Generic Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Generic Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Generic Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Generic Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
FRANCE
Generic Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
GERMANY
Generic Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
UNITED KINGDOM
Generic Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
SPAIN
Spain Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
RUSSIA
Russia Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Generic Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Generic Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Generic Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Generic Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
AUSTRALIA
Generic Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
Australia Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Australia Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
INDIA
Generic Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
India Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
India Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
SOUTH KOREA
South Korea Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
South Korea Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
LATIN AMERICA
Generic Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
Latin America Recent Past, Current & Future Analysis for Generic Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Generic Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Generic Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
ARGENTINA
Argentina Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Argentina Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
BRAZIL
Brazil Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Brazil Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
MEXICO
Mexico Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Mexico Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
Rest of Latin America Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Rest of Latin America Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
MIDDLE EAST
Generic Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
Middle East Recent Past, Current & Future Analysis for Generic Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Generic Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Generic Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
IRAN
Iran Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Iran Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
ISRAEL
Israel Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Israel Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
SAUDI ARABIA
Saudi Arabia Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Saudi Arabia Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
UAE Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
UAE Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
Rest of Middle East Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Rest of Middle East Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
AFRICA
Generic Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
Africa Recent Past, Current & Future Analysis for Generic Drugs by Type - Small-Molecule Generics and Biosimilars - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Generic Drugs by Type - Small-Molecule Generics and Biosimilars Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Generic Drugs by Type - Percentage Breakdown of Value Sales for Small-Molecule Generics and Biosimilars for the Years 2012, 2021 & 2027
Africa Recent Past, Current & Future Analysis for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Generic Drugs by Therapeutic Application - Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Generic Drugs by Therapeutic Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Oncology, Respiratory and Other Therapeutic Applications for the Years 2012, 2021 & 2027
Total Companies Profiled: 42

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com